Hint mode is switched on Switch off

SBIO - Invesco NASDAQ Biotech UCITS ETF Acc (USD) (IE00BQ70R696)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
IE00BQ70R696
SBIO ISIN
Exchange Traded Funds (ETF)
Type of fund
Invesco
Provider
61.89 USD
NAV per Share | 04/06/2026
06/11/2014
Inception Date
No
Dividend payments
CEOGMS
CFI
SBIO
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
NASDAQ Biotechnology Index
Benchmark
0.4 %
Total Cost Ratio
414.92 mln USD
Fund NAV | 04/06/2026
414.92 mln USD
Share Class NAV | 04/06/2026
Yes
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 18/05/2026, London S.E. (USD)

  • YTD
    0.46 %
  • 1M
    -6.54 %
  • 3M
    -4.7 %
  • 6M
    2.64 %
  • 1Y
    43.58 %
  • 3Y
    39.77 %
  • 5Y
    -
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (SBIO)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

SBIO profile

The Invesco NASDAQ Biotech UCITS ETF Acc (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Invesco fund’s base currency is USD and the share class was registered 06.11.2014 with unique ISIN - IE00BQ70R696. Main exchange is London S.E. (USD) and ticker symbol is SBIO. The total expense ratio is 0.4%. The Invesco NASDAQ Biotech UCITS ETF Acc (USD) pays dividends 0 time(s) per year.

Structure SBIO on 03/06/2026

Download structure in Excel
Paper Value
AMGEN ORD 7.36%
GILEAD SCIENCES ORD 7.32%
VERTEX PHARMACEUTICALS ORD 7.29%
REGENERON PHARMACEUTICALS ORD 5.28%
ALNYLAM PHARMACEUTICALS ORD 3.19%
REVOLUTION MEDICINES ORD 2.54%
BIOGEN ORD 2.36%
ILLUMINA ORD 2.15%
UNITED THERAPEUTICS ORD 1.98%
ROYALTY PHARMA CL A ORD 1.93%
ARGENX ADR REP ORD 1.89%
INSMED ORD 1.84%
ROIVANT SCIENCES ORD 1.69%
INCYTE ORD 1.6%
MODERNA ORD 1.59%
VIATRIS ORD 1.47%
GUARDANT HEALTH ORD 1.37%
NEUROCRINE BIOSCIENCES ORD 1.36%
JAZZ PHARMACEUTICALS ORD 1.17%
EXELIXIS ORD 1.1%
ASCENDIS PHARMA ORD 1.1%
MEDPACE HOLDINGS ORD 1.05%
BRIDGEBIO PHARMA ORD 1.04%
IONIS PHARMACEUTICALS ORD 1%
AXSOME THERAPEUTICS ORD 0.98%
SUMMIT THERAPEUTICS ORD 0.96%
MADRIGAL PHARMACEUTI ORD 0.92%
BIOMARIN PHARMACEUTICAL ORD 0.86%
SANOFI 2 ADR REP ORD 0.85%
ARROWHEAD PHARMACEUTICALS ORD 0.83%
BIONTECH SE ADR 0.83%
BEONE MEDICINES ADS REP ORD 0.73%
KRYSTAL BIOTECH ORD 0.72%
CYTOKINETICS ORD 0.72%
TEMPUS AI CL A ORD 0.68%
HALOZYME THERAPEUTICS ORD 0.68%
PRAXIS PRECISION MEDICINES ORD 0.64%
IMMUNITYBIO ORD 0.61%
ALKERMES ORD 0.59%
VAXCYTE ORD 0.55%
NUVALENT CL A ORD 0.54%
IMMUNOVANT ORD 0.52%
PROTAGONIST THERAPEUTICS ORD 0.5%
KYMERA THERAPEUTICS ORD 0.49%
RHYTHM PHARMACEUTICALS ORD 0.48%
SPYRE THERAPEUTICS ORD 0.47%
PTC THERAPEUTICS ORD 0.47%
MIRUM PHARMACEUTICALS ORD 0.46%
ABIVAX SA ADR 0.45%
COGENT BIOSCIENCES ORD 0.43%
CRISPR THERAPEUTICS ORD 0.41%
CENTESSA PHARMACEUTICALS ADR 0.39%
LIGAND PHARMACEUTICALS ORD 0.38%
APOGEE THERAPEUTICS ORD 0.38%
CG ONCOLOGY ORD 0.38%
SCHOLAR ROCK HOLDING ORD 0.37%
XENON PHARMACEUTICALS ORD 0.37%
TWIST BIOSCIENCE ORD 0.36%
INDIVIOR PHARMACEUTICALS ORD 0.36%
CARIS LIFE SCIENCES ORD 0.36%
TRAVERE THERAPEUTICS ORD 0.34%
ERASCA ORD 0.34%
AMNEAL PHARMACEUTICALS CL A ORD 0.33%
EDGEWISE THERAPEUTICS ORD 0.32%
VERACYTE ORD 0.32%
10X GENOMICS CL A ORD 0.31%
NEWAMSTERDAM PHARMA ORD 0.3%
ACADIA PHARMACEUTICALS ORD 0.3%
CRINETICS PHARMACEUTICALS ORD 0.28%
DENALI THERAPEUTICS ORD 0.26%
LEGEND BIOTECH 2 ADR REP ORD 0.25%
BEAM THERAPEUTICS ORD 0.25%
DYNE THERAPEUTICS ORD 0.24%
STRUCTURE THERAPEUTICS ADR 0.24%
TANGO THERAPEUTICS ORD 0.24%
ORUKA THERAPEUTICS ORD 0.23%
RELAY THERAPEUTICS ORD 0.22%
DISC MEDICINE ORD 0.22%
ARCUTIS BIOTHERAPEUTICS ORD 0.22%
ALUMIS ORD 0.21%
SUPERNUS PHARMACEUTICALS ORD 0.21%
TARSUS PHARMACEUTICALS ORD 0.21%
IDEAYA BIOSCIENCES ORD 0.2%
ADAPTIVE BIOTECHNOLOGIES ORD 0.2%
GRAIL ORD 0.2%
DEFINIUM THERAPEUTICS ORD 0.19%
VERA THERAPEUTICS CL A ORD 0.18%
KINIKSA PHARMACEUTICALS INT CL A ORD 0.18%
ULTRAGENYX PHARMACEUTICAL ORD 0.18%
ENLIVEN THERAPEUTICS ORD 0.18%
AURINIA PHARMACEUTICALS ORD 0.17%
BIOCRYST PHARMACEUTICALS ORD 0.17%
KODIAK SCIENCES ORD 0.17%
MINERALYS THERAPEUTICS ORD 0.16%
PHARVARIS N V ORD 0.16%
UNIQURE ORD 0.15%
HARMONY BIOSCIENCES HLDG ORD 0.15%
ADMA BIOLOGICS ORD 0.15%
NOVOCURE ORD 0.15%
ZYMEWORKS ORD 0.15%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.